Tag - Respiratory Motion

Senzime outlicenses ExSpiron in the Chinese market

Antonette Ho2023-06-27T00:33:52-04:00Uppsala, June 19, 2023. Senzime AB (publ), a leader in the field of peri- and post-operative patient monitoring solutions, has today entered into an exclusive license agreement with the Chinese company CoreSpiron (Henan) Co Ltd. The agreement grants CoreSpiron up to 10 years of manufacturing and sales rights for Senzime's ExSpiron system in the Chinese market... ExSpiron is part of the product portfolio of Respiratory Motion Inc., which Senzime acquired in 2022. The product is based on clinical research and...

Senzime to acquire Respiratory Motion

Ziad2022-11-25T13:59:45-05:00Senzime has signed an agreement to acquire 100 percent of the shares in the US company Respiratory Motion, Inc. for an initial consideration of 19 million USD on a cash- and debt-free basis with an additional potential earn-out payment of up to 25 million USD, paid out earliest in 2024. Read more >>

New Directors Join the Board at Respiratory Motion Inc.

Ziad2022-11-25T14:02:28-05:00 Respiratory Motion Inc. (RMI) today announced the appointment of Chas Taylor and Bob Smouse, MD, FACR to the Board of Directors, Chas Taylor has been named Chairman of the Board, and Bob Smouse the President of the company, overseeing day to day operations. Read more >>

Respiratory Motion, Inc. Awarded National Group Breakthrough Technologies Purchasing Contract by Premier

Ziad2022-11-25T14:04:54-05:00Respiratory Motion, Inc. is announcing the award of a group purchasing agreement as a Breakthrough Technology with Premier Inc., a leading healthcare improvement company. Read more >>

Noninvasive Respiratory Volume Monitoring Effective for Nonintubated Colonoscopy Patients

Ziad2022-11-25T14:04:54-05:00The monitor—ExSpiron (Respiratory Motion Inc.)—provides continuous monitoring of minute ventilation, tidal volume and respiratory rate. The monitor has a sensor that goes across the patient’s chest. Read more >>

Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron™ 1Xi Minute Ventilation Monitor in Pediatric Patients

Ziad2022-11-25T14:05:06-05:00Respiratory Motion, Inc. reported today that FDA clearance was received for the newest version of its ExSpiron Minute Ventilation (MV) monitoring system on Friday March 16th and announced its plan to launch the new ExSpiron at the Society for Pediatric Anesthesia-American Academy of Pediatrics in Phoenix, March 23-25. Read more >>

Respiratory Motion, Inc. and Corestone Biosciences (Beijing) Co., Ltd., have established a Joint Venture Company to deliver monitoring solutions to Chinese healthcare market and the globe

Ziad2022-11-25T14:05:29-05:00Respiratory Motion, Inc. (Waltham, Massachusetts, USA) the global leader in minute ventilation monitoring and Corestone Biosciences Co., Ltd., an innovative medical device company in anesthesia and analgesia headquartered in Beijing, China have entered into an agreement to form a Joint Venture Company (JV). The JV will offer a new generation of Respiratory Volume Monitors based on Respiratory Motion's ExSpiron platform, along with other novel critical care solutions for hospital and home markets. The JV will operate out of Zhengzhou in...

Respiratory Motion Inc., is excited to announce the launch of the latest ExSpiron 1Xi™ Respiratory Monitor

Ziad2022-11-25T14:05:29-05:00Respiratory Motion, Inc., announced today its plans to launch the newest version of its ExSpiron 1Xi™ Minute Ventilation (MV) Monitor at the American Society of Anesthesiologists (ASA) in Boston, October 21-25 following recent FDA 510(k) clearance. This new ExSpiron requires no calibration, which greatly expands its range of use. Physicians, nurses, respiratory therapists, EMT's and first responders can now easily assess and measure a patients breathing in seconds. Read more >>